[2]
WHO, U. UNFPA, The World Bank. Trends in maternal mortality:
1990 to 2010. World Health Organization, UNICEF, UNFPA, and
The World Bank, 2018.
[5]
Bashandy, S.; Jaleel, G.; Abdallah, H.; Harraz, S. Therapeutic implications of thymoquinone in the management of diabetes mellitus and its complications. Am. J. Phytomed. Clin. Therap., 2015, 3(3), 287-301.
[8]
Kumaraguruparan, R.; Seshagiri, P.B.; Hara, Y.; Nagini, S. Chemoprevention of rat mammary carcinogenesis by black tea polyphenols: Modulation of xenobiotic‐metabolizing enzymes, oxidative stress, cell proliferation, apoptosis, and angiogenesis. Mol. Carcinog., 2007, 46(9), 797-806.
[11]
Pearson-Stuttard, J.; Zhou, B.; Kontis, V.; Bentham, J.; Gunter, M.J.; Ezzati, M. Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: A comparative risk assessment.. Lancet Diabetes Endocrinol., 2018, 6, e6-15.
[13]
Kaushik, P.; Kaushik, P.P.D. A comprehensive review on medicinal
plants with anticancer activity. Global J. Pharm. Educ. Res., 2018, 3(1-2)
[15]
Amin, B.; Hosseinzadeh, H. Black cumin (Nigella sativa) and its
active constituent, thymoquinone: An overview on the analgesic and
anti-inflammatory effects. Planta medica, 82(01/02), 2016, 8-16.
[16]
Ahmad, A.; Khan, R.M.A.; Alkharfy, K.M.; Raish, M.; Al-Jenoobi, F.I.; Al-Mohizea, A.M. Effects of thymoquinone on the pharmacokinetics and pharmacodynamics of glibenclamide in a rat model., Nat.
Prod. Commun, 2015, 10(8), 1934578X1501000821.
[18]
Falah, R.R.; Talib, W.H.; Shbailat, S.J. Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis. Ther. Adv. Med. Oncol., 2017, 9(4), 235-252.
[19]
Dong-Dong, W.; Yi-Zhen, M.; Su-Mei, H.; Chen, X. Analysis of time course and dose effect from metformin on body mass index in children and adolescents. Front. Pharmacol., 2021, 12, 611480.
[21]
Salani, B.; Del Rio, A.; Marini, C.; Sambuceti, G.; Cordera, R.; Maggi, D. Metformin, cancer and glucose metabolism. Endocr. Relat. Cancer, 2014, 21(6), R461-R471.
[22]
da Trindade, M.T.; Kogawa, A.C.; Salgado, H.R.N. Metformin: A review of characteristics, properties, analytical methods and impact in the green chemistry. Crit. Rev. Anal. Chem., 2018, 48(1), 66-72.
[39]
Bobbin, M.L.; Rossi, J.J. RNA interference (RNAi)-based therapeutics: Delivering on the promise? Annu. Rev. Pharmacol. Toxicol., 2019, 56, 103-122.
[40]
Yeo, E.J.; Chun, Y.S.; Cho, Y.S.; Kim, J.; Lee, J.C.; Kim, M.S.; Park, J.W. YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1. J. Natl. Cancer Inst., 2003, 95(7), 516-525.
[41]
Mirmiran, P.; Bahadoran, Z.; Ghasemi, A.; Hosseinpanah, F. Type 2 diabetes and cancer: An overview of epidemiological evidence and potential mechanisms. Crit. Rev. Oncogen., 2019, 24(3), 223-233.